These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 4110671

  • 1. Effect of long-term levodopa treatment on drug metabolism in rat liver.
    Arvela P, Kärki NT, Nieminen L, Möttönen M.
    Lancet; 1972 Feb 19; 1(7747):439-40. PubMed ID: 4110671
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of drug metabolism by levodopa in combination with a dopa-decarboxylase inhibitor.
    Vesell ES, Ng L, Passananti GT, Chase TN.
    Lancet; 1971 Aug 14; 2(7720):370. PubMed ID: 4105063
    [No Abstract] [Full Text] [Related]

  • 3. The effect of dexamethasone and actinomycin D on cytochrome P-450 dependent drug metabolism in rat adjuvant arthritis.
    Hirschelmann R, Müller D.
    Pharmazie; 1986 Sep 14; 41(9):669-70. PubMed ID: 3797463
    [No Abstract] [Full Text] [Related]

  • 4. The influence of hormones on hepatic function.
    Song CS, Kappas A.
    Prog Liver Dis; 1970 Sep 14; 3():89-109. PubMed ID: 4908718
    [No Abstract] [Full Text] [Related]

  • 5. Effect of chronic L-DOPA administration of catecholamine metabolism in the rat.
    Lancaster J, Sawyer PR, Shepherd DM, Turnbull MJ.
    Br J Pharmacol; 1973 Apr 14; 47(4):838-42. PubMed ID: 4723802
    [Abstract] [Full Text] [Related]

  • 6. The effect of chronic oral ketoconazole on in vivo drug metabolism in the rat.
    Jiritano L, Bortolotti A, Bonati M.
    Res Commun Chem Pathol Pharmacol; 1986 Nov 14; 54(2):173-80. PubMed ID: 3786944
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of phthalate esters on drug metabolizing enzyme activities in rat liver.
    Aitio A, Parkki M.
    Arch Int Pharmacodyn Ther; 1978 Oct 14; 235(2):187-95. PubMed ID: 736698
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of the hepatotoxicity of trichloroethylene by inducers of drug metabolism.
    Carlson GP.
    Res Commun Chem Pathol Pharmacol; 1974 Mar 14; 7(3):637-40. PubMed ID: 4363358
    [No Abstract] [Full Text] [Related]

  • 10. Drug metabolism and therapeutics.
    Conney AH.
    N Engl J Med; 1969 Mar 20; 280(12):653-60. PubMed ID: 4974536
    [No Abstract] [Full Text] [Related]

  • 11. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ, Porter CC.
    J Pharmacol Exp Ther; 1970 Apr 20; 172(2):406-15. PubMed ID: 5441162
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Absorption, distribution, metabolism, and excretion of griseofulvin in man and animals.
    Lin C, Symchowicz S.
    Drug Metab Rev; 1975 Apr 20; 4(1):75-95. PubMed ID: 1106976
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M, Kettler R, Zürcher G, Schaffner R, Haefely WE.
    Eur Neurol; 1987 Apr 20; 27 Suppl 1():9-20. PubMed ID: 3123242
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.